InspireMD (NSPR) Cash & Equivalents (QoQ) (2010 - 2025)
InspireMD (NSPR) Cash & Equivalents (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | InspireMD | 57.98 Mn | 3.77 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -85.90% |
| Sep 30, 2025 | 450.90% |
| Jun 30, 2025 | -7.06% |
| Mar 31, 2025 | -34.54% |
| Dec 31, 2024 | 19.59% |
| Sep 30, 2024 | -44.27% |
| Jun 30, 2024 | 202.32% |
| Mar 31, 2024 | -2.60% |
| Dec 31, 2023 | -30.34% |
| Sep 30, 2023 | 19.87% |
| Jun 30, 2023 | 173.06% |
| Mar 31, 2023 | -8.72% |
| Dec 31, 2022 | 17.74% |
| Sep 30, 2022 | -38.46% |
| Jun 30, 2022 | -18.02% |
| Mar 31, 2022 | -35.04% |
| Dec 31, 2021 | -8.08% |
| Sep 30, 2021 | -68.47% |
| Jun 30, 2021 | -5.94% |
| Mar 31, 2021 | 248.23% |